Stockscreener 앱 받기
0.327
17.13%
-0.0676
시간 외 거래:
.35
0.023
+7.03%
전일 마감가:
$0.3946
열려 있는:
$0.3781
하루 거래량:
1.57M
Relative Volume:
2.07
시가총액:
$13.70M
수익:
-
순이익/손실:
$-17.78M
주가수익비율:
-0.5954
EPS:
-0.5492
순현금흐름:
$-10.52M
1주 성능:
-22.31%
1개월 성능:
-40.46%
6개월 성능:
-67.62%
1년 성능:
-89.24%
1일 변동 폭
$0.3181
$0.389
1주일 범위
$0.3181
$0.4201
52주 변동 폭
$0.3181
$3.89
Fibrobiologics Inc Stock (FBLG) Company Profile
명칭
Fibrobiologics Inc
전화
281-671-5150
주소
455 E. MEDICAL CENTER BLVD, HOUSTON
FBLG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FBLG
Fibrobiologics Inc
|
0.327 | 16.53M | 0 | -17.78M | -10.52M | -0.5492 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-12 | 개시 | Rodman & Renshaw | Buy |
| 2024-10-30 | 개시 | H.C. Wainwright | Buy |
| 2024-09-24 | 개시 | Maxim Group | Buy |
Fibrobiologics Inc 주식(FBLG)의 최신 뉴스
How FibroBiologics Inc. (SG0) stock performs in easing cyclesEarnings Performance Report & Safe Capital Growth Trade Ideas - newser.com
Is FibroBiologics Inc. (SG0) stock included in top ETFsInflation Watch & Risk Controlled Stock Pick Alerts - newser.com
What earnings revisions data tells us about FibroBiologics Inc.Oil Prices & AI Forecast Swing Trade Picks - newser.com
Should you hold or exit FibroBiologics Inc. nowJuly 2025 Technicals & Community Trade Idea Sharing Platform - newser.com
How FibroBiologics Inc. stock performs in interest rate cyclesEarnings Summary Report & Risk Managed Investment Signals - newser.com
D. Boral Capital Maintains FibroBiologics (FBLG) Buy Recommendation - Nasdaq
What’s the recovery path for long term holders of FibroBiologics Inc.Trade Signal Summary & Risk Adjusted Buy and Sell Alerts - newser.com
When is the best time to exit FibroBiologics Inc.2025 Earnings Surprises & Reliable Entry Point Trade Alerts - newser.com
How sustainable is FibroBiologics Inc. stock dividend payoutLayoff News & Accurate Intraday Trading Signals - newser.com
FBLG Analyst Ratings: Jason Kolbert Maintains Buy Stance | FBLG Stock News - GuruFocus
Is FibroBiologics Inc. (SG0) stock ideal for retirement investorsJuly 2025 Selloffs & Consistent Income Trade Ideas - newser.com
Is FibroBiologics Inc. (SG0) stock resilient in recession scenariosDividend Hike & Smart Allocation Stock Reports - newser.com
How dovish Fed policy supports FibroBiologics Inc. (SG0) stockWeekly Investment Recap & Smart Investment Allocation Tips - newser.com
Identifying reversal signals in FibroBiologics Inc.Weekly Profit Report & Community Verified Trade Signals - newser.com
Sector ETF performance correlation with FibroBiologics Inc.Trade Analysis Report & Verified Chart Pattern Trade Signals - newser.com
Real time scanner hits for FibroBiologics Inc. explainedStock Surge & Free Technical Confirmation Trade Alerts - newser.com
Analyzing recovery setups for FibroBiologics Inc. investorsQuarterly Trade Report & Breakout Confirmation Alerts - newser.com
What data driven models say about FibroBiologics Inc.’s futureTrade Signal Summary & Short-Term High Return Strategies - newser.com
Why institutional investors increase stakes in FibroBiologics Inc. (SG0) stock2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com
FibroBiologics, Inc. (FBLG) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
What drives FibroBiologics Inc stock priceTrading Volume Surges & Free Tools to Monitor Market Corrections - earlytimes.in
FibroBiologics Advances Manufacturing and IND Preparations for Clinical Trials of CYWC628, CYPS317, and CYMS101 - Quiver Quantitative
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
FibroBiologics, Inc. SEC 10-Q Report - TradingView
FibroBiologics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
FibroBiologics warns on going concern amid $15M notes - Stock Titan
Is FibroBiologics Inc. stock gaining market shareMarket Activity Recap & Precise Buy Zone Tips - newser.com
Fibrobiologics Inc (FBLG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):